Insider Transactions in Q1 2022 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2022
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Open market or private sale
|
Direct |
3,634
-10.04%
|
$210,772
$58.24 P/Share
|
|
Mar 10
2022
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,602
-5.33%
|
$205,314
$57.92 P/Share
|
|
Mar 10
2022
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,901
+3.84%
|
-
|
|
Mar 10
2022
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,221
-8.53%
|
$183,597
$57.92 P/Share
|
|
Mar 10
2022
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,987
+8.85%
|
-
|
|
Mar 10
2022
|
Merdad Parsey Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,505
-7.83%
|
$199,785
$57.92 P/Share
|
|
Mar 10
2022
|
Merdad Parsey Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,612
+8.17%
|
-
|
|
Mar 10
2022
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
935
-3.4%
|
$53,295
$57.92 P/Share
|
|
Mar 10
2022
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,297
+5.79%
|
-
|
|
Mar 10
2022
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,089
-5.45%
|
$119,073
$57.92 P/Share
|
|
Mar 10
2022
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,723
+7.21%
|
-
|
|
Mar 10
2022
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,052
-4.24%
|
$629,964
$57.92 P/Share
|
|
Mar 10
2022
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,003
+4.51%
|
-
|
|
Mar 01
2022
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,245
-8.95%
|
$1,394,700
$60.26 P/Share
|
|
Mar 01
2022
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
54,284
+9.58%
|
-
|
|
Feb 15
2022
|
Merdad Parsey Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
348
+0.83%
|
$18,096
$52.13 P/Share
|
|
Feb 15
2022
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
348
+1.05%
|
$18,096
$52.13 P/Share
|
|
Feb 15
2022
|
Andrew D Dickinson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
348
+0.54%
|
$18,096
$52.13 P/Share
|
|
Feb 09
2022
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Open market or private sale
|
Direct |
1,691
-4.93%
|
$106,533
$63.89 P/Share
|
|
Feb 06
2022
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
520
-2.1%
|
$32,760
$63.9 P/Share
|
|
Feb 06
2022
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,864
+7.01%
|
-
|
|
Feb 06
2022
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,036
-2.93%
|
$65,268
$63.9 P/Share
|
|
Feb 06
2022
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,727
+7.17%
|
-
|
|
Feb 06
2022
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
767
-1.27%
|
$48,321
$63.9 P/Share
|
|
Feb 06
2022
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,817
+2.92%
|
-
|
|
Feb 01
2022
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Open market or private sale
|
Direct |
14,061
-30.15%
|
$956,148
$68.54 P/Share
|
|
Jan 26
2022
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
5,681
-10.86%
|
$380,627
$67.34 P/Share
|
|
Jan 26
2022
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
35,004
+29.65%
|
-
|
|
Jan 26
2022
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,616
-5.81%
|
$242,272
$67.34 P/Share
|
|
Jan 26
2022
|
Andrew D Dickinson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,176
+22.68%
|
-
|
|
Jan 26
2022
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
394
-1.69%
|
$26,398
$67.34 P/Share
|
|
Jan 26
2022
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
2,871
+5.97%
|
-
|
|
Jan 26
2022
|
Merdad Parsey Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,298
+35.33%
|
-
|
|
Jan 26
2022
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
33,833
-14.15%
|
$2,266,811
$67.34 P/Share
|
|
Jan 26
2022
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
146,678
+27.36%
|
-
|
|
Jan 26
2022
|
Johanna Mercier Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,630
+37.71%
|
-
|